Stay updated on Pembrolizumab in HCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in HCC Clinical Trial page.

Latest updates to the Pembrolizumab in HCC Clinical Trial page
- Check3 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedAdded hepatocellular carcinoma keyword and a new Genetic and Rare Diseases Information Center resources link. Revision updated to v3.5.0.SummaryDifference0.2%

- Check39 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3. This is an internal versioning change and does not affect user-facing content.SummaryDifference0.1%

- Check68 days agoChange DetectedAdded Revision: v3.4.2 and removed the lapse notice about government funding and the related Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check75 days agoChange DetectedAdded a government funding notice about the NIH Clinical Center status and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check82 days agoChange DetectedAdded a 'Show glossary' option and updated status labels to 'Last Update Submitted that Met QC Criteria' with a 'No FEAR Act Data' indicator and revision 'v3.4.0'. The previous wording 'Last Update Submitted that met QC Criteria', the 'No FEAR Act data' term, and revision 'v3.3.4' were removed.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in HCC Clinical Trial page.